Overview

The Letrozole Administration During Luteal Phase

Status:
Unknown status
Trial end date:
2017-03-01
Target enrollment:
0
Participant gender:
Female
Summary
To investigate the effect of letrozole in patients who have high risk of ovarian hyperstimulation syndrome (OHSS) after oocyte retrieval, the incidence of OHSS were calculated between letrozole group and supporting treatment group.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
The Affiliated Hospital of Inner Mongolia Medical University
Treatments:
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate
Letrozole
Polygeline
Criteria
Inclusion criteria:

1. oocyte is more than or equal to 20;

2. hCG injection on serum estradiol levels greater than or equal to 5000 pmol/L; 3. on
the day of oocyte unilateral or bilateral ovarian diameter greater than or equal to 10
cm;

4. follicle puncture is larger than or equal to number 20.

Exclusion criteria:

Allergic to the letrozole or polygeline.